Lakefront Biotherapeutics (LKFT) Goodwill & Intangibles (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Goodwill & Intangibles for 13 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 98.29% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 98.29% YoY), while the FY2025 annual figure was $4.5 million, down 98.22% from the prior year.
• Goodwill & Intangibles declined to $4.1 million in Q1 2026 per LKFT's latest filing, from $4.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $266.8 million in Q3 2024 and bottomed at $4.1 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $173.8 million across 5 years, with a median of $226.0 million in 2023.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles jumped 276.64% — and 2026, when it plunged 98.29%.
• Lakefront Biotherapeutics' Goodwill & Intangibles stood at $251.5 million in 2022, then climbed by 4.73% to $263.4 million in 2023, then declined by 4.73% to $251.0 million in 2024, then plunged by 98.22% to $4.5 million in 2025, then decreased by 8.95% to $4.1 million in 2026.
• Business Quant data shows LKFT's Goodwill & Intangibles at $4.1 million in Q1 2026, $4.5 million in Q4 2025, and $12.3 million in Q3 2025.